A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...
New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
Today, a patient diagnosed with advanced prostate cancer has options. Doctors can offer a suite of androgen-suppressing drugs to extend his life. There are genetic tests that can show whether he’s a ...
LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...
LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...
A study found microplastics in prostate tumors, with higher levels in cancer tissue, prompting further research into potential links and health effects. In a recent small, single-center study ...
I am a cancer researcher and a cancer survivor. A few nights ago, I came across a post on X by @NIH that (seemingly) proudly announced massive cuts to the indirect cost rate on all current and future ...
Over the past decade, millions of men without symptoms of prostate cancer have voluntarily undergone a prostate-specific antigen (PSA) test in the UK to find out if they might have prostate cancer.
Dozens of motorcycle riders in Wilmington will suit up in their best vintage style for the Distinguished Gentleman’s Ride.